Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Oberlin

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Archives of Internal Medicine|December 22, 1999
Thyroid carcinomas after irradiation for a first cancer during childhoodF de Vathaire, C Hardiman, A Shamsaldin, et al.
British Journal of Cancer|April 17, 1999
Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentF de Vathaire, M Hawkins, S Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric OncologyB Pellegrino, M J Terrier-Lacombe, O Oberlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)A Ferrari, G L De Salvo, B Brennan, et al.
Pediatric Hematology and Oncology|December 15, 2016
Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelinesE Seror, J Donadieu, H Pacquement, et al.
Klinische Padiatrie|May 19, 2015
Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in EuropeT Bölling, G Braun-Munzinger, S Burdach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Archives of Internal Medicine|December 22, 1999
Thyroid carcinomas after irradiation for a first cancer during childhoodF de Vathaire, C Hardiman, A Shamsaldin, et al.
British Journal of Cancer|April 17, 1999
Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentF de Vathaire, M Hawkins, S Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric OncologyB Pellegrino, M J Terrier-Lacombe, O Oberlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)A Ferrari, G L De Salvo, B Brennan, et al.
Pediatric Hematology and Oncology|December 15, 2016
Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelinesE Seror, J Donadieu, H Pacquement, et al.
Klinische Padiatrie|May 19, 2015
Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in EuropeT Bölling, G Braun-Munzinger, S Burdach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Pageof 10